International Journal of Cardiology
Volume 136, Issue 2 , Pages 186-192, 14 August 2009

Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis

  • Ana Ruigómez

      Affiliations

    • Spanish Centre for Pharmacoepidemiological Research (CEIFE), Madrid, Spain
    • Corresponding Author InformationCorresponding author. Spanish Centre for Pharmacoepidemiological Research (CEIFE), Almirante 28, 2°, 28004 Madrid, Spain. Tel.: +34 91 531 1485; fax: +34 91 531 2871.
  • ,
  • Saga Johansson

      Affiliations

    • AstraZeneca R&D, Mölndal, Sweden
    • Section of Preventive Cardiology, Gothenburg University, Sweden
  • ,
  • Mari-Ann Wallander

      Affiliations

    • AstraZeneca R&D, Mölndal, Sweden
    • Department of Public Health and Caring Science, Uppsala University, Sweden
  • ,
  • Nils Edvardsson

      Affiliations

    • AstraZeneca R&D, Mölndal, Sweden
    • Sahlgrenska University Hospital, Gothenburg, Sweden.
  • ,
  • Luis Alberto García Rodríguez

      Affiliations

    • Spanish Centre for Pharmacoepidemiological Research (CEIFE), Madrid, Spain

Received 15 October 2007; received in revised form 1 February 2008; accepted 25 April 2008. published online 14 July 2008.

Abstract 

Background

Atrial fibrillation (AF) is associated with subsequent cardiovascular events including ischemic stroke, transient ischemic events, and coronary events. This study aimed to evaluate the risk of ischemic cerebrovascular events (ICVE), coronary events (CE) or heart failure (HF) following a diagnosis of AF.

Methods

Patients were selected from the UK General Practice Research Database. The incidence of ICVE, CE and HF was determined during a 6-year follow-up period for patients with a first diagnosis of AF (n=831) and a control group without AF (n=8226). Relative risk of developing a cardiovascular event associated with prior AF and other potential risk factors was estimated using Cox regression analysis.

Results

A first diagnosis of ICVE, CE or HF was made in 261 patients in the AF group and 622 in the control group. The relative risks associated with AF were 2.1 for CE (95% CI: 1.6–2.9), 3.0 for ICVE (95% CI: 2.3–4.0) and 6.4 for HF (95% CI: 5.0–8.3). The risks of CE, HF and ICVE were higher in patients with chronic AF than paroxysmal AF (odds ratio: 1.5, 95% CI: 1.0–2.2) and in patients aged at least 60 years or with diabetes. Lifestyle factors did not significantly affect the risk of cardiovascular events in patients with AF.

Conclusions

After a first episode of AF there is an increased risk of ICVE, CE and HF. Patients initially diagnosed with chronic AF have a higher risk than those with paroxysmal AF.

Keywords: Atrial fibrillation, Ischemic cerebrovascular accident, Heart failure, Coronary event, Epidemiology, Primary health care

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Disclosures: this study was funded by a research grant from AstraZeneca R&D Mölndal, Sweden. Dr Wallander, Dr Johansson and Dr Edvardsson are employees of AstraZeneca. Dr Ruigómez and Dr García Rodríguez work for CEIFE, which has received research grants from AstraZeneca. The corresponding author had full access to all the data in the study, and takes responsibility for the integrity of the data and the accuracy of the data analysis.

PII: S0167-5273(08)00630-X

doi:10.1016/j.ijcard.2008.04.050

International Journal of Cardiology
Volume 136, Issue 2 , Pages 186-192, 14 August 2009